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Functional Characterization of a Novel Family of Acetylcholine-Gated
Chloride Channels in Schistosoma mansoni
Abstract
Acetylcholine is the canonical excitatory neurotransmitter of the mammalian neuromuscular system.
However, in the trematode parasite Schistosoma mansoni, cholinergic stimulation leads to muscle relaxation
and a flaccid paralysis, suggesting an inhibitory mode of action. Information about the pharmacological
mechanism of this inhibition is lacking. Here, we used a combination of techniques to assess the role of
cholinergic receptors in schistosome motor function. The neuromuscular effects of acetylcholine are typically
mediated by gated cation channels of the nicotinic receptor (nAChR) family. Bioinformatics analyses
identified numerous nAChR subunits in the S. mansoni genome but, interestingly, nearly half of these subunits
carried a motif normally associated with chloride-selectivity. These putative schistosome acetylcholine-gated
chloride channels (SmACCs) are evolutionarily divergent from those of nematodes and form a unique clade
within the larger family of nAChRs. Pharmacological and RNA interference (RNAi) behavioral screens were
used to assess the role of the SmACCs in larval motor function. Treatment with antagonists produced the
same effect as RNAi suppression of SmACCs; both led to a hypermotile phenotype consistent with
abrogation of an inhibitory neuromuscular mediator. Antibodies were then generated against two of the
SmACCs for use in immunolocalization studies. SmACC-1 and SmACC-2 localize to regions of the
peripheral nervous system that innervate the body wall muscles, yet neither appears to be expressed directly
on the musculature. One gene, SmACC-1, was expressed in HEK-293 cells and characterized using an iodide
flux assay. The results indicate that SmACC-1 formed a functional homomeric chloride channel and was
activated selectively by a panel of cholinergic agonists. The results described in this study identify a novel
clade of nicotinic chloride channels that act as inhibitory modulators of schistosome neuromuscular function.
Additionally, the iodide flux assay used to characterize SmACC-1 represents a new high-throughput tool for
drug screening against these unique parasite ion channels.
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regions of the peripheral nervous system that innervate the body wall muscles, yet neither appears to be expressed directly
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results indicate that SmACC-1 formed a functional homomeric chloride channel and was activated selectively by a panel of
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Introduction
Flatworms of the genus Schistosoma are the causative agents of the
debilitating parasitic infection schistosomiasis, afflicting over 230
million people in 74 endemic countries [1]. The majority of human
schistosomiasis can be attributed to three species- S. mansoni, S.
japonicum and S. haematobium- which cause a wide spectrum of
chronic pathology, including hepatosplenomegaly, portal hyperten-
sion and squamous cell carcinoma [1]. Currently, praziquantel
(PZQ) is the only drug used to treat schistosomiasis and there is no
vaccine available. Widespread and exclusive use of PZQ has led to
concerns of emerging drug resistance. Laboratory strains of PZQ-
resistant S. mansoni have been successfully generated and there are
now several reports of reduced PZQ cure rates in the field [2,3].
Moreover, PZQ is ineffective in killing larval schistosomulae [4].
The stage-limited efficacy of PZQ and looming prospect of drug
resistance signal the importance of exploring novel therapeutic
targets for the treatment of schistosomiasis.
An area of interest for the treatment of helminth parasites is the
neuromuscular system, which is targeted by the majority of
currently approved and marketed anthelminthics [5]. Inhibition of
neuromuscular activity provides two modes of treatment. First,
motor inhibition may interfere with parasite maturation, which is
closely tied with migration during the larval stage [6]. Second, a
loss of muscle function would disrupt essential activities, including
attachment to the host, feeding, mating and others [7], ultimately
causing the parasite to be eliminated from the host. The
cholinergic system has proved especially successful as a neuro-
muscular anthelminthic target. Common antinematodal drugs
such as levamisole, pyrantel and monepantel [5,8], and the
antischistosomal drug, metrifonate [9], all disrupt neuromuscular
signaling by interacting with proteins of the worm’s cholinergic
system.
Acetylcholine (ACh) is an important neurotransmitter in both
vertebrate and invertebrate species. The neuromuscular effects of
ACh are typically mediated by postsynaptic nicotinic acetylcholine
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receptors (nAChRs), so named because of their high-affinity for
nicotine. Structurally, nAChRs are members of the Cys-loop
ligand-gated ion channel (LGIC) superfamily. They form homo-
and heteropentameric structures, which are organized in a barrel
shape around a central ion-selective pore [10]. Vertebrate
nAChRs are invariably cation-selective (Na+, Ca2+, K+) and
mediate excitatory responses. Invertebrates, on the other hand,
have both cation and anion-selective (Cl2) ACh-gated channels.
The latter mediate Cl2 - driven membrane hyperpolarization and
therefore are believed to play a role in inhibitory responses to
ACh. One example of these unique invertebrate receptors is the
acetylcholine-gated chloride channel (ACC) of the snail, Lymnaea,
which is structurally related to nAChRs, yet is selective for chloride
ions [11]. In addition, nematodes have an unusual type of ACC,
which is a functional acetylcholine-gated chloride channel but is
more closely related to other chloride channels (GABA and glycine
receptors) than nAChRs [12–13]. A defining feature of the ACCs
is the presence of a Pro-Ala motif in the pore-lining M2 domains of
the constituent subunits. This motif, which has been shown to
confer anion-selectivity to other LGICs, replaces a Glu residue
normally found in the cation-selective channels [14].
ACCs have not been identified in any of the flatworms, free-living
or parasitic. However, there is experimental evidence supporting an
inhibitory role for ACh in the parasites, which could be mediated by
this type of receptor. Early studies in the 1960s observed that
addition of exogenous cholinergic agonists to parasite cultures
caused flaccid paralysis of adult trematodes and cestodes [15–16].
Flaccid paralysis indicates muscular relaxation and is in direct
contradiction to the excitatory response of tonic contraction
expected from cholinergic stimulation. Later research established
a causal relationship between activation of a nicotinic-like receptor
in S. mansoni muscle fibers and the flaccid paralysis caused by ACh in
whole worms [17]. However, this work was performed in the pre-
genomic era and no attempt was made to clone or characterize the
receptors involved. More recently, the publication of the S. mansoni
genome [18] has provided cause to revisit the unusual inhibitory
activity of ACh in schistosomes. Several candidate genes have been
annotated as nAChR subunits [18–19] and the present work aims to
confirm the presence of and functionally characterize cholinergic
chloride channels in S. mansoni.
One strategy that has been used for assessing the therapeutic
value of candidate genes in parasites, particularly helminths, is
RNA interference (RNAi) [20–22]. A strength of this reverse
genetics strategy is the ability to screen living animals for
phenotypic and behavioral changes as a result of abrogation of a
particular gene’s function, as demonstrated by the large-scale
screens in the free-living platyhelminth cousins of schistosomes, the
planarians [23]. The RNAi pathway is conserved in S. mansoni
[20–21] and has previously been used to probe the neuropepti-
dergic system of the parasite [24] and, more recently, the
serotonergic system as well [25]. However, the effects of silencing
other important neuroactive pathways, such as the cholinergic
system, are not known.
Here we describe a novel clade of anion-selective nAChR
subunits (SmACCs) that appear to be invertebrate-specific. The
ion channels formed by these subunits play an inhibitory role in
the neuromuscular activity of the parasite, as suggested by the
results of RNAi and pharmacological behavioral assays, their
tissue distribution and pharmacological properties.
Materials and Methods
Parasites
A Puerto Rican strain of S. mansoni-infected Biomphalaria glabrata
snails were kindly provided by Dr. Fred Lewis (Biomedical
Research Institute and BEI Resources, MD, USA) and used for all
experiments. To obtain larval schistosomula, 6–8 week-old snails
were exposed to bright light for 2 hours at room temperature. The
resulting cercarial suspension was mechanically transformed in vitro
by vortexing, washed twice with Opti-MEM (Gibco) containing
0.25 mg/ml fungizone, 100 mg/ml streptomycin and 100 units/ml
penicillin and cultured in Opti-MEM/antibiotics supplemented
with 6%FBS (Gibco) [26]. To obtain adult worms, 40-day old
female CD1 mice were injected intraperitoneally with 250
mechanically transformed schistosomula [26]. After 8 weeks, adult
worms were collected by perfusion of the mouse hepatic portal
vein and mesenteric venules, as previously described [26]. Animal
procedures were reviewed and approved by the Facility Animal
Care Committee of McGill University (Protocol No. 3346) and
were conducted in accordance with the guidelines of the Canadian
Council on Animal Care.
Bioinformatics
To generate a target list of putative nicotinic acetylcholine
receptor (nAChR) subunits, the S. mansoni Genome Database was
searched using the keywords ‘‘nicotinic’’ and ‘‘acetylcholine
receptor’’ [18–19]. A BLASTp homology search was also
performed using the Torpedo nAChR (AAA96704.1) as a query.
The resulting list of nAChR subunit sequences was used as a query
against the general NCBI protein database and aligned with other
Cys-loop receptor superfamily proteins by CLUSTALX [27]. The
alignments were analyzed manually to identify the presence of the
vicinal C motif, indicative of nAChR a-subunits, and key amino
acids involved in ion-selectivity. Phylogenetic trees were built in
PHYLIP using the neighbor-joining method and bootstrapped
with 1,000 replicates [28]. Trees were visualized and annotated
using FigTree3.0 [29] and manually inspected to ensure that
bootstrap values for each node were above a 70% threshold.
siRNA Design and Synthesis
Five putative nAChR subunits were targeted by RNA
interference (RNAi): Smp_157790, Smp_037960, Smp_132070,
Smp_176310 (SmACC-1) and Smp_142690 (SmACC-2). For
each target sequence, we amplified a unique 200–300 bp PCR
Author Summary
Schistosomiasis is a widespread, chronic disease affecting
over 200 million people in developing countries. Currently,
there is no vaccine available and treatment depends on
the use of a single drug, praziquantel. Reports of reduced
praziquantel efficacy, as well as its ineffectiveness against
larval schistosomula highlight the need to develop new
therapeutics. Interference with schistosome motor func-
tion provides a promising therapeutic target due to its
importance in a variety of essential biological processes.
The cholinergic system has been shown previously to be a
major modulator of parasite motility. In this study, we have
described a novel clade of schistosome acetylcholine-
gated chloride channels (SmACCs) that act as inhibitory
modulators of this pathway. Our results suggest that these
receptors are absent in the human host and indirectly
modulate inhibitory neuromuscular responses, making
them an attractive drug-target. We have also validated a
new functional assay to characterize these receptors,
which may be modified for future use as a high-
throughput drug screening method for parasite chloride
channels.
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fragment by RT-PCR. Total RNA was extracted from pooled
adult male and female S. mansoni, using the RNeasy Micro Kit
(Qiagen) and reverse-transcribed with MML-V (Invitrogen) and
Oligo-dT (Invitrogen). PCR amplification was performed with a
proofreading Phusion High Fidelity Polymerase (New England
Biolabs), according to standard protocols. PCR primers (Table S2)
were designed using Oligo6.2 [30] and the unique fragment
sequences were identified by BLAST analysis. Amplicons were
ligated to the pJET1.2 Blunt Vector (Fermentas) and verified by
sequencing of multiple clones. For synthesis of double-stranded
RNAs (dsRNA), the T7 promoter sequence (59-TAATACGACT-
CACTATAGGGAGA-39) was added to both ends of each target
fragment by PCR. Long dsRNAs were generated from the
resulting T7-flanked PCR products by in vitro transcription of
both DNA strands, using the MegaScript T7 Transcription Kit
(Ambion), according to the kit protocol. The dsRNAs were
subsequently digested with RNAseIII, using the Silencer siRNA
Kit (Ambion), to generate a mixture of siRNAs for each target.
The siRNA was quantitated and assessed for purity using a
Nanodrop ND1000 spectrophotometer.
Transfection of Schistosomula and Motility Assays
Larval schistosomula were obtained by the standard protocol
(see above) with some modification. After the final wash, freshly
transformed schistosomula were re-suspended in Opti-MEM
without antibiotics or FBS and plated at a concentration of 100
animals/well in a 24-well plate. Animals were transfected using
siPORT NEO FX Transfection Agent (Ambion) and either an
irrelevant scrambled siRNA (Ambion) or nAChR subunit-specific
siRNA at a final concentration of 50 nM. Transfections were
performed blind to rule out selection bias during analysis. Opti-
MEM containing antibiotics and supplemented with 6%FBS was
added to transfected schistosomula 24 hours post-treatment. A
previously described larval motility assay was performed 6 days
post-transfection [31]. Briefly, schistosomula were filmed for 45s
using a Nikon SMZ1500 microscope equipped with a digital video
camera (QICAM Fast 1394, mono 12 bit, QImaging) and
SimplePCI version 5.2 (Compix Inc.) software. Three distinct
fields were recorded for each well. ImageJ (version 1.41, NIH,
USA) software was then used to quantitate worm motility using the
Fit Ellipse algorithm in ImageJ, as described [25]. The data shown
here are derived from three independent experiments in which a
minimum of 12 animals was measured per experiment. Pharma-
cological motility assays were carried out with 6-day old
schistosomulae in the same manner, but without the transfection
with siRNA. Baseline measurements of schistosomula motility
were recorded prior to drug addition. Compounds of interest
(arecoline, nicotine, mecamylamine, D-tubocurarine) were subse-
quently added at a final concentration of 100 mM and larval
motility was measured again after 5 minutes exposure. Viability of
drug-treated and siRNA-treated schistosomula was routinely
monitored by a dye exclusion assay, according to the method of
Gold [32].
Real-Time Quantitative PCR
Six-day old siRNA-treated schistosomula were washed twice
with 1X PBS, re-suspended in the lysis buffer provided with the
RNEasy Micro RNA Extraction Kit (Qiagen) and sonicated with 6
pulses of 10 s each. Total RNA was then extracted from the lysate
following the manufacturer’s instructions. RNA was quantified
and assessed for purity using a Nanodrop ND1000 spectropho-
tometer. 100 ng total RNA was used for each 20 ml MML-V
(Invitrogen) reverse transcription (RT) reaction, which was
performed according to standard protocols. A negative control
lacking reverse transcriptase was also prepared in order to rule out
contamination with genomic DNA. Quantitative real-time PCR
(qPCR) was performed using the Platinum SYBR Green qPCR
SuperMix-UDG kit (Invitrogen) in a 25 ml reaction volume.
Primers located in a unique region of each gene and separate from
those regions used to generate siRNA were designed using
Oligo6.2 and may be found in Table S2. Primers targeting the
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase
(GAPDH, Accession #M92359) were used as an internal control
and are as follows: forward 59-GTTGATCTGACATGTAGGT-
TAG- 39 and reverse 59-ACTAATTTCACGAAGTTGTTG-39.
Primer validation curves were generated to ensure similar
efficiency of target and housekeeping gene amplification. Cycling
conditions were as follows: 50uC/2 min, 95uC/2 min, followed by
50 cycles of 94uC/15 s, 57uC/30 s, 72uC/30 s. Cycle threshold
(Ct) values were normalized to GAPDH and then compared to the
scrambled siRNA control, as well as an off-target gene (another
nAChR subunit) to ensure transcript-specific silencing. All
expression data was analyzed using the comparative DDCt method
[33] and was generated from three separate experiments done in
triplicate.
Cloning of Full Length SmACC-1 and SmACC-2
Two putative anion-selective subunit sequences, Smp_176310
(SmACC-1) and Smp_142690 (SmACC-2) were chosen for further
study and cloned by conventional RT-PCR (see above) using
primers targeting the beginning and end of each cDNA. For
SmACC-1 we used primers: forward 59-ATGGATCTAATA-
TACTTG-39 and reverse: 59-TTAGGTAGTTTCTTCTG-39.
PCR conditions were as follows: 98uC/30 s, 30 cycles of 98uC/
10 s, 55uC/60 s, 72uC/90 s and final extension of 72uC/5 min. In
the case of SmACC-2, the full-length cDNA was amplified with
primers 59-ATGGAAAAATCACTTATTCG-39 (forward) and
59-TTATTGTAGATCAACTACG-39 (reverse), using the follow-
ing cycling conditions: 98uC/30 s, 30 cycles of 98uC/10 s, 54uC/
60 s, 72uC/60 s and a final extension of 72uC/5 min. The 59 end
of SmACC-2 was further verified by 59 RACE (rapid amplification
of cDNA ends), using a commercial kit (Invitrogen) and a gene-
specific primer for the reverse transcription [59-GCAGGTACA-
TAATCTGAG-39], according to manufacturer’s instructions. All
PCR products were ligated to the pJet1.2 Blunt cloning vector
(Thermo Scientific) and verified by DNA sequencing of at least
two independent clones.
Antibody Production
Peptide-derived polyclonal antibodies were generated in rabbits
against subunits SmACC-1 and SmACC-2 (21st Century Bio-
chemicals – Marlborough, MA). Animals were injected with a
mixture of two specific peptides per target. For SmACC-1, the two
peptides 1(NAKVNRFGKPHGNKFC) and 2(CSKKALSAA-
NAKWNSPLQY) are located in the third intracellular loop of
the protein. For SmACC-2, peptide 1 (TDGEAERHIR-
HEDRVHQLRSVC) and peptide 2 (LQNINMKQIK-
LEYKNSLGC) are located at the N- and C-terminal ends,
respectively. All peptides were conjugated to the carrier protein
ovalbumin and were BLASTed against the S. mansoni genome
database and the NCBI general database to ensure specificity.
Whole antisera were tested for specificity and titer against both
immunogenic peptides by ELISA. The anti-nAChR-specific IgG
fractions were affinity-purified, using beads that were covalently
attached to a mixture of the two peptide antigens added in equal
amounts. Peptide conjugation to the beads and subsequent affinity
purification were performed with the Pierce Sulfolink Kit
for Peptides (Thermo Scientific), according to manufacturer’s
Cholinergic Chloride Channels in Schistosomes
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instructions. ELISA was performed to determine the titer of
affinity-purified antibody fractions. Protein was quantified by the
Bradford assay, using a commercial kit (BioRad, USA). A
mouse monoclonal anti-FLAG M2 antibody was purchased from
Sigma-Aldrich.
Confocal Microscopy
Parasites were prepared for confocal microscopy according to
previously described protocols [34,35]. Briefly, 6-day old in-vitro-
transformed schistosomula or freshly collected adult worms were
washed two times in 1X PBS and fixed in 4%PFA for 4 hours at
4uC. Parasites were washed twice, each for 5 minutes in 1X PBS
containing 100 mM glycine and then permeabilized with 1%SDS
in 1X PBS for 25 minutes [36]. After permeabilization, animals
were incubated overnight at 4uC in antibody diluent (AbD)
containing 0.1%Tween-20, 1% BSA in PBS to block non-specific
binding. After 3 washes of 10 minutes each in the AbD, animals
were then incubated with affinity-purified anti-SmACC-1 or anti-
SmACC-2 (1:100) for three days at 4uC. Samples were then
washed 3 times in AbD and incubated in secondary antibody
(1:1000) conjugated to Alexa Fluor 488 or 594 (Invitrogen, USA).
In some experiments, tetramethylrhodamine B isothiocyanate
(TRITC)-conjugated phalloidin (200 mg/ml) was added with
secondary antibody and used to visualize the musculature.
Secondary antibody incubation lasted for 2 days and animals
were again washed three times before mounting for microscopy.
Slides were examined using a Zeiss LSM710 confocal microscope
(Carl Zeiss Inc., Canada) equipped with the Zeiss Zen 2010
software package. The lasers used for image acquisition were an
Argon 488 nm and a HeNe 594 nm, with the filter sets adjusted to
minimize bleed-through due to spectral overlap. Negative control
slides were prepared by incubating samples in pre-immune serum,
secondary antibody only (primary antibody was omitted) or
primary antibody preadsorbed with 0.5 mg/mL of mixed peptide
antigen (0.25 mg/ml of each peptide). At least 5 independent
samples were examined for each peptide-derived antibody.
Western Blot Analysis
Membrane-enriched protein fractions were extracted from adult
S. mansoni using the ProteoExtract Native Membrane Protein
Extraction Kit (Calbiochem, USA) and following the manufactur-
er’s instructions. Protein was quantified by the Bradford Assay
(BioRad, USA) and used for SDS-PAGE and Western blot analysis.
Approximately 20 mg of membrane extract was loaded on a 4–12%
Tris-Glycine gel (Invitrogen, USA) and resolved by SDS-PAGE,
then transferred to a PVDF membrane (Millipore, USA). A
standard Western blot protocol was followed to visualize proteins.
Primary antibodies used were peptide-purified anti-SmACC-1 or
anti-SmACC-2 (both 1:1000). Secondary antibody (1:5000) was
goat-anti-rabbit conjugated to horseradish peroxidase (Invitrogen,
USA). Membranes were also probed with peptide antigen-
preadsorbed primary antibody (1:1000) as a negative control.
Heterologous Expression and Functional Characterization
of SmACC-1 in HEK-293 Cells
For mammalian expression studies, a human codon-optimized
construct of SmACC-1 was synthesized (Genescript, USA) and
inserted into the pCi-Neo (Promega) expression vector, using NheI
and SmaI restriction sites. A C-terminal FLAG tag was also
included in the SmACC-Neo construct to aid in the monitoring of
expression. HEK-293 cells were grown to 50% confluence in
Dulbecco’s Modified Essential Media (DMEM) supplemented with
20 mM HEPES and 10% heat inactivated fetal calf serum. Cells
were transiently transfected with the humanized SmACC-1
construct or empty vector, using XtremeGENE 9 transfection
reagent (Roche), as recommended by the manufacturer. 24 hours
post-transfection, cells were transduced with Premo Halide Sensor
(Invitrogen), a halide-sensitive fluorescent indicator used to assess
ligand-gated chloride channel function [37–38]. Following trans-
duction, cells were incubated at 37uC, 5% CO2 overnight and
seeded onto a 96-well plate at a density of 50,000 cells per well.
After an 8 hour incubation at 37uC, 5% CO2, the cells were
equilibrated with iodide assay buffer provided with the Premo
Halide Sensor assay kit for at least 30 minutes at 37uC in the
reading chamber of a FlexStation II scanning fluorometer
(Molecular Devices). YFP fluorescence was measured for 10 s
before and up to 2 minutes after the addition of test agonists.
Agonists were added at a final concentration of 100 mM, or as
indicated, in a total sample volume of 200 ml. Water was used as a
vehicle-only negative control. Antagonist assays were performed
the same way, except the cells were pre-incubated with 100 mM
cholinergic antagonist (mecamylamine, D-tubocurarine, atropine)
for 30 min at 37uC prior to addition of 100 mM nicotine. Receptor
activity was calculated by measuring the reduction in YFP
fluorescence (YFP quench) due to iodide influx over the time of
measurement. Briefly, a fluorescence measurement was taken 10 s
after the addition of drug (Relative fluorescence (RF)initial) and
again after a period of 120 s (RFfinal). The RFfinal was subtracted
from the RFinitial to generate DRF. DRF was then divided by the
RFinitial and multiplied by 100, resulting in a measurement of
%YFP quench, as described [38]. Readings were normalized to
water-treated controls and reported as Fold-Change in YFP
Quench [39]. Receptor activation was also calculated by the
linear-regression slope method [40] with similar results. The
minimum quench threshold for all experiments was set at zero
[41]. Dose response curves were fitted using the non-linear
regression function of Prism 6 software (Graphpad Software,
USA). Student’s t-tests were performed to determine statistically
significant differences at P,0.05.
Other Methods
Calcium assays were performed using the Calcium 4 FLIPR
Assay Kit (Molecular Devices, USA) with a FlexStation II
fluorometer (Molecular Devices), according to the kit protocol
and as described previously [42]. Briefly, HEK-293 cells
expressing SmACC-1 were preloaded with a cell-permeable
fluorescent calcium indicator 48 hr post-transfection, as per the
kit protocol, and treated with 100 mM nicotine, 100 mM acetyl-
choline or water vehicle. The concentration of calcium in the
extracellular medium was <2 mM. Intracellular calcium was
measured before addition of agonist to obtain a baseline and
immediately following agonist addition at 1.52 s intervals for a
total of 120 s. Calcium responses were calculated as peak
fluorescence levels after subtraction of the baseline, as described
[42], and experiments were repeated twice (two independent
transfections), each with six replicates. In situ immunofluorescence
assays in transfected HEK-293 cells were performed according to
standard protocols, using either affinity-purified anti-SmACC-1
antibody (1:500) or a commercial monoclonal anti-FLAG (M2)
antibody, as described previously [43].
Results
Identification of Acetylcholine-Gated Chloride Channel
Subunits in S. mansoni (SmACCs)
A combination of BLAST and keyword searches were used to
generate a list of potential nAChR subunits in the genome
Cholinergic Chloride Channels in Schistosomes
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database of S. mansoni [18]. In total, nine putative receptor subunits
were identified. All sequences were predicted to have the defining
features of a nAChR subunit, including a Cys-loop motif and four
transmembrane domains [44] and all subunit genes identified are
predicted to contain full-length coding sequences. A structural
alignment of the putative schistosome nAChR subunits with two
previously characterized human nAChR alpha subunits, the
Lymnaea nicotinic chloride channels and the crystal structure of
the Torpedo nAChR suggests the presence of both cation and
anion-selective schistosome nAChR subunits. Figure 1 shows the
M2 domain of the structural alignment in which the Torpedo,
human and two of the schistosome receptor subunits contain a
conserved glutamate at the M2 interface, which is the hallmark of
cation-selective Cys-loop channels. In contrast, the remaining
schistosome nAChR subunits, including SmACC-1 (Smp_176310)
and SmACC-2 (Smp_142690) and the Lymnaea subunits display a
Pro-Ala motif at this position. The Pro-Ala motif is associated with
anion-selectivity in Cys-loop receptors [14]. Previous mutagenesis
studies have shown that replacing the M2 glutamate of a
vertebrate nAChR with Pro-Ala is sufficient to convert the ion-
selectivity of the channel from cationic to anionic [45, 46, see 47
for review].
The predicted schistosome nAChRs were then aligned with
cation and anion-selective Cys-loop receptor subunits from other
representative vertebrate and invertebrate species, including the
acetylcholine-gated chloride channel (ACC) subunits from C.
elegans [12]. A phylogenetic tree of the alignment (Figure 2) shows
the unique clade formed by the Pro-Ala motif-containing
schistosome nAChR subunits is located firmly in the larger group
of cation-selective nAChR subunits. Also present in this clade are
the nicotinic chloride channel subunits of the snail Lymnaea [11]
and putative homologs from fellow flatworms Clonorchis and
Dugesia. This is in contrast to the C. elegans ACC subunits, which
group more closely to the anion-selective GABA/glycine receptors
and have low affinity for nicotine [12]. Thus, the nAChR subunits
in schistosomes are all structurally related to cation-selective
nicotinic receptors but those carrying the Pro-Ala motif appear to
have diverged and may have acquired selectivity for anions. The
structural relationship of the schistosome sequences to known
chloride-selective nAChRs of Lymnaea reinforces the notion that
these are nicotinic anion channels. Moreover, the presence of
putative homologs in closely related flatworms and their apparent
absence in host species indicate that these receptors may be good
targets for broad-spectrum antiparasitics.
Two of the predicted anion-selective subunits, SmACC-1 and
SmACC-2 were selected for full-length cloning. SmACC-1
contains a predicted ORF of 2415 bp distributed over 9 exons,
encoding a protein of 92 kDa. SmACC-1 contains an N-
terminal signal peptide and an N-terminal double cysteine motif
(YxCC) that is the defining characteristic of nAChR alpha-type
subunits [48]. Full-length SmACC-1 was successfully amplified
by PCR and sequencing of multiple SmACC-1 clones verified
the predicted ORF (GenBank accession # KF694748). The
coding sequence of SmACC-2 was predicted to be 2745 bp.
However, further sequence analysis by BLAST predicted a large
(,1 kb) N-terminal nucleotide-binding domain (NBD), a feature
not normally present in Cys-loop receptors. This excess
sequence may have been a result of the concatenation of two
distinct proteins during annotation. To identify the correct start
codon of SmACC-2, 59RACE experiments were performed and
an alternative start site downstream of the predicted start codon
was identified, removing the NBD sequence. New PCR primers
were designed and full-length SmACC-2 was amplified, resulting
in a product of 1528 bp and a corresponding protein of 60 kDa
(GenBank accession # KF694749). The new SmACC-2 coding
sequence was in frame with the predicted ORF and retained
both its Cys-loop and transmembrane domains but does not
contain a signal peptide. SmACC-2 also lacks the vicinal
cysteine motif, suggesting that it is a non-alpha-type nAChR
subunit.
Schistosome nAChRs Act as Inhibitory Modulators of
Motor Function
A previously described behavioral assay [25,31] was used to
evaluate the effect of cholinergic compounds on S. mansoni larval
motility. Animals were treated with either cholinergic agonists
(arecoline, nicotine) or antagonists (mecamylamine, D-tubocura-
rine) alone at a concentration of 100 mM and the frequency of
body movements (shortening and elongation) was calculated as a
measure of motility [25,31]. Treatment of 6-day old schistosom-
ula with cholinergic agonists caused rapid, near complete
paralysis when compared to the water-treated controls
(Figure 3A). Conversely, the nicotinic antagonists caused a 2-
3.5-fold increase in larval motility. These results are consistent
with previous studies [reviewed in 49] and support the hypothesis
that cholinergic receptors inhibit neuromuscular function in S.
mansoni.
To examine the role of the predicted anion-selective nAChR
subunits in larval motor behavior, we targeted individual nAChR
subunits by RNA interference (RNAi), using pooled sequence–
specific siRNAs. A mock–transfected sample (lipid transfection
reagent only) and a nonsense scrambled siRNA control were
included as negative controls; there was no significant decrease in
motor behavior in either control compared to untransfected
larvae. In contrast, animals treated with nAChR siRNAs all
showed a significant (P,0.05) hyperactive motor phenotype
(Figure 3B). Depending on the subunit, the increase in larval
motility ranged from 2-4-fold when compared to the negative
scrambled control. The two subunits generating very strong
Figure 1. Predicted ion-selectivity of putative S. mansoni
nAChRs. A structural alignment of human, Lymnaea and S. mansoni
nAChR subunits was generated using the Torpedo nAChR structure
(PDB Accession# 2BG9) as a template. The M1-M2 linker region, shown
here, is a key determinant of ion-selectivity in Cys-loop ligand gated ion
channels. A glutamate residue (arrow) confers cation-selectivity and is
present in all vertebrate subunits, as well as two of the S. mansoni
subunits. The remaining schistosome and snail subunits display a Pro-
Ala motif in this position, suggesting anion-selectivity. The two subunits
described in this study are identified as S. mansoni acetylcholine-gated
chloride channels SmACC-1 and SmACC-2. Other S. mansoni subunits
are identified by their ‘‘Smp’’ designation obtained from the S. mansoni
Genome Database (S. mansoni GeneDB). The corresponding GenBank
accession numbers are listed in Table S1.
doi:10.1371/journal.ppat.1004181.g001
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hyperactive phenotypes were SmACC-2 (,6-fold) and SmACC-1
(,4.5-fold). The hyperactivity in the nAChR RNAi-treated
animals is consistent with the phenotype seen in animals where
nAChR activity has been pharmacologically abrogated by
receptor antagonists (Figure 3A).
Knockdown at the mRNA level was confirmed by quantitative
qPCR for SmACC-1 and SmACC-2 (Figure 4A). SmACC-2
expression was reduced 60% at the transcript level and SmACC-1
expression was reduced by 90%. In both cases the knockdown was
observed only in RNAi-suppressed larvae, indicating the effect was
specific. Transfection with SmACC-1 siRNAs had no effect on the
expression level of the other subunit, SmACC-2, or vice-versa
(Figure 4A). Knockdown at the protein level was confirmed by
western blot analysis of SmACC-1, using a specific antibody
(Figure 4B). The siRNA-treated animals show a drastic reduction
in protein expression, as evidenced by the absence of the expected
92 kDa band in the treated sample lane, whereas no difference
was seen in the loading control.
Immunolocalization of SmACC-1 and SmACC-2
In order to determine the tissue localization of SmACC-1 and
SmACC-2, we obtained custom commercial antibodies against
each target. Polyclonal antibodies were generated using two
unique peptide antigens for each gene of interest, each peptide
being conjugated to ovalbumin. The antibodies were peptide
affinity-purified and tested by ELISA and western blotting. Adult
worm membrane fractions probed with anti-SmACC-1 antibody
showed a predominant band at <100 kDa. Probing with
antibodies specific for SmACC-2 resulted in a single band of
< 65 kDa. These bands are slightly larger than the predicted sizes
Figure 2. Phylogenetic analysis of cys-loop ion channel subunits. A bootstrapped, neighbor-joining tree was constructed in PHYLIP from a
CLUSTALX alignment of vertebrate and invertebrate Cys-loop superfamily receptor subunits. The tree is midpoint-rooted and was visualized using
FigTree 3.0. Only nodes supported by bootstrap values of 70% or higher are shown. Two distinct groups of receptors can be seen, the c-aminobutyric
acid (GABA)/glycine-like anion channels and the nicotinic acetylcholine receptors (nAChRs). The C. elegans acetylcholine-gated chloride channels
(ACC) form a distinct clade within the larger group of GABA/glycine anion channels (green inset). In contrast the predicted Schistosoma acetylcholine-
gated chloride channels (SmACCs) align with cholinergic nicotinic nAChRs, suggesting divergent evolutionary paths. The SmACCs described here are
indicated by arrows and they constitute a separate clade in the nAChR tree along with putative homologs from flatworms Dugesia (Dtig), Clonorchis
(Cs) and S. haematobium, as well as the snail Lymnaea (Lym). Accession numbers for sequences used in the alignment are listed in Table S1.
doi:10.1371/journal.ppat.1004181.g002
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(92 kDa and 60 kDa, respectively), possibly due to glycosylation of
the native proteins. Control samples in which the antibody was
pretreated with an excess of peptide antigen (preadsorbed control)
showed no immunoreactivity, indicating specificity of binding for
the intended protein.
For the immunolocalization study, adult and larval schistosomes
were stained with either anti-SmACC-1 or anti-SmACC-2 and an
Alexa-488 conjugated secondary antibody. Some animals were
counterstained with TRITC-conjugated phalloidin to label muscle
and cytoskeletal features. The results suggest that SmACC-1 and
Figure 3. Pharmacological and RNAi behavioral assays in schistosomula. (A) Relative motility of 6-day old larvae was measured before and 5
minutes after the addition of cholinergic compounds, each at 100 mM. Data were normalized to baseline motility measured before drug addition. The
data are the means and SEM of three independent experiments, each containing at least 12 animals. (B) Freshly transformed schistosomula were
transfected with 50 nM irrelevant (scrambled) siRNA or 50 nM siRNA targeting a specific subunit. The following subunits were targeted in this study
(refer to Table S1 for Accession numbers): Smp_157, Smp_157790; Smp_132, Smp_132070; Smp_037, Smp_037960; SmACC-1, Smp_176310; SmACC-
2, Smp_142690. Larval motility was measured 6 days post-transfection and normalized relative to untransfected larvae cultured for the same period
of time. The data shown are the means of three independent experiments, each containing at least 12 animals. *Significantly different from the
scrambled siRNA control at P,0.05.
doi:10.1371/journal.ppat.1004181.g003
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SmACC-2 are both localized to the peripheral nervous system
(PNS) of the worm (Figure 5), a region that is rich in cholinergic
neurons [50,51]. Cholinergic neurons are also present in the brain
and main nerve cords of the central nervous system (CNS) [50,51]
but we did not observe significant labeling in these regions, either
with anti-SmACC-1 or anti-SmACC-2 antibodies. Within the
PNS, SmACC-1 immunoreactivity can be seen in fine varicose
nerve fibers, resembling beads on a string, which are repeated
along the length of the body (Figure 5 A). Close inspection of the
confocal stacks suggests these are minor nerve cords of the vast
submuscular plexus that innervates the body wall muscles [52].
Similarly anti-SmACC-2 staining revealed numerous varicose
nerve fibers in the peripheral innervation of the body wall
(Figure 5B). Some of these nerve fibers can be seen criss-crossing
the length of the body, where they come into close contact with the
musculature. However there was no visible overlay between the
antibody labeling (green) and the phalloidin-stained muscles (red),
either for SmACC-2 (Figure 5B) or SmACC-1, suggesting these
receptors are expressed in nerve tissue rather than the muscle
itself. Other regions where specific immunoreactivity was detected
included the nerve plexuses of the suckers, which were labeled by
both anti-SmACC-1 and 2 antibodies, and the surface of the
worm. Surface labeling was observed only with the anti-SmACC-2
antibody and it occurred in both males and females, though it was
particularly enriched in the male tubercles (Figure 5C). It is
unknown if this labeling is associated with the tegument itself or
possibly sensory nerve endings that are present on the surface of
the worm. No comparable fluorescence could be seen in any of the
negative controls tested, including a peptide-preadsorbed antibody
control (Figure 5E, F) and therefore the labeling is considered to be
specific.
Immunolocalization studies were repeated in larval schistosom-
ula and the labeling patterns of SmACC-1 and 2 were found to be
similar. In both cases, immunoreactivity occurred in a network of
fine varicose nerve fibers that run just below the surface and along
the entire length of the body (Figure 5D). This resembles the
expression pattern seen in the adults and suggests the receptor is
expressed in the developing PNS of the larvae. As with the adults,
we were unable to detect specific labeling in the CNS of the larvae
with either antibody.
SmACC-1 Forms a Functional, Nicotinic Chloride Channel
HEK-293 cells were transfected with codon-optimized (human-
ized) SmACC-1 and protein expression was monitored by in situ
immunofluorescence. SmACC-1 was selected for these studies
because it is a predicted alpha-like subunit and therefore it is
capable, in principle, of forming functional homomeric channels
[10]. Initial attempts to express the native (non-humanized)
SmACC-1 proved unsuccessful. The codon-optimized sequence,
however, expressed significant levels of protein in the HEK-293
cells. The transfected cells were immunoreactive for SmACC-1
when probed either with specific antibody (Figure 6A) or anti-
FLAG antibody targeting the C-terminal FLAG epitope. No
immunofluorescence was noted in the negative control cells
transfected with empty plasmid (Figure 6B).
Cells expressing codon-optimized SmACC-1 were transduced
with a YFP sensor (Premo Halide Sensor) and seeded on a 96-well
plate for the iodide (I2) flux assay. The principle of the assay has
been described in detail [37–40] and is shown schematically in
Figure 6C. Cells expressing a chloride channel of interest are
bathed in an iodide buffer, which serves as a surrogate for chloride
(Cl2) anions. After a period of equilibration, test compounds are
added and if the chloride channel of interest is activated, an influx
of I2 occurs, quenching the fluorescence of the YFP sensor.
Channel activity was quantified by measuring either the slope of
the curve or the decrease in fluorescence following drug addition,
as described [39]. Figure 6D shows representative tracings of cells
expressing SmACC-1 and mock-transfected cells, each treated
with 100 mM nicotine. Activation of SmACC-1 (red circles) by
nicotine caused a significant decrease in YFP fluorescence
compared to nicotine-treated mock-transfected cells (black circles).
No significant reduction in fluorescence was seen in SmACC-1
Figure 4. Confirmation of SmACC knockdown. (A) Knockdown of SmACC-1 and SmACC-2 was confirmed at the mRNA level. Schistosomula
were transfected with subunit-specific siRNA or scrambled siRNA control, as indicated. RNA was extracted at 6 days post-transfection, oligo-dT
reverse-transcribed and quantitative qPCR was performed using primers targeting either a specific subunit or a non-relevant SmACC subunit as an
off-target control. Relative expression was calculated using the comparative DDCt method after normalization to a housekeeping gene (GAPDH). The
data are derived from three independent experiments, each with 3 replicates, and are shown as the % remaining expression relative to the scrambled
siRNA control. Silencing of both subunits was statistically significant, as measured by a Student’s t-test at P,0.05 (B) Western blot analysis was
performed to assay for silencing of SmACC-1 at the protein level. Crude membrane protein extracts from SmACC-1 siRNA-treated and negative
control schistosomula were resolved on a SDS-PAGE gel, transferred to a PVDF membrane and probed with affinity-purified anti-SmACC-1 or a
loading control (anti-Sm5-HTR [74]). A band of the expected size (arrow) is present in the scrambled negative control lane but not in the SmACC-1
siRNA-treated lane.
doi:10.1371/journal.ppat.1004181.g004
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expressing cells treated with water, suggesting the YFP quench was
agonist-dependent. In separate experiments, we also tested
whether SmACC-1 was able to transport calcium in the HEK-
293 cells, using a kit-based calcium fluorescence assay. This was
done in part to verify the ion selectivity of the channel and also to
address the possibility that the YFP quench might be due to
indirect activation of an endogenous calcium-sensitive chloride
channel. However these experiments showed no evidence of
calcium influx through SmACC-1. Cells expressing SmACC-1
were treated with 100 mM nicotine or 100 mM ACh and there was
no effect of either agonist on intracellular calcium levels (data not
shown). Thus we rule out an indirect effect of calcium on I2
transport and conclude that SmACC-1 is a cholinergic anion
channel, as predicted from the bioinformatics analysis.
The I2 flux (YFP sensor) experiments were repeated with
different test substances and the results are shown in Figure 7.
None of the compounds used stimulated a significant influx of I2
in the mock control. In contrast the cells expressing SmACC-1
were responsive to several cholinergic agonists, particularly
nicotine. Treatment with nicotine (100 mM) caused a significant
(P,0.05) <6-fold increase in YFP quench in cells expressing
SmACC-1. Smaller but statistically significant responses were also
seen with other cholinergic agonists (ACh, choline chloride,
carbachol and arecoline). Non-cholinergic substances, including
biogenic amines (serotonin (5HT), dopamine) and glutamate, had
no effect on the cells (Figure 7). These data suggest that SmACC-1
is capable of forming a functional homomeric chloride channel
that displays a preference for nicotine and related cholinergic
substances. Furthermore, SmACC-1 was activated by nicotine in a
dose-dependent manner with an EC50 = 4.361.4 mM (Figure 7,
inset). To test if the channel is sensitive to inhibition by cholinergic
antagonists, SmACC-1 – expressing cells were treated with
nicotine (100 mM) in the presence and absence of ‘‘classical’’
(mammalian) nicotinic antagonists (D-tubocurarine, mecamyl-
amine) or the muscarinic (GAR) antagonist, atropine, each at
100 mM. Of the drugs tested, only D-tubocurarine was able to
significantly block the activation of SmACC-1 by nicotine
(Figure 8). The other two drugs, mecamylamine and atropine
were ineffective at this concentration.
Discussion
Acetylcholine (ACh) has long been known as the quintessential
excitatory neurotransmitter of the vertebrate neuromuscular
system. Signaling through cation-selective nAChRs, ACh mediates
muscular contraction via membrane depolarization due to an
influx of Na+ or Ca2+. More recently, a distinct class of anion-
selective nAChRs and other types of acetylcholine-gated chloride
channels (ACCs) has been reported in several invertebrate
organisms, including mollusks and nematodes [11,12]. These
Figure 5. Immunolocalization of SmACC-1 and SmACC-2 in Schistosoma mansoni. Adult and 6-day old schistosomula were fixed and
incubated with affinity-purified anti-SmACC-1 or anti-SmACC-2, followed by Alexa 488-conjugated secondary antibody (green). In some animals the
body wall musculature was counterstained with tetramethylrhodamine B isothiocyanate (TRITC)-labeled phalloidin (red). (A) A Z-projection of
SmACC-1 immunoreactivity in an adult male worm. SmACC-1 is present in both the oral sucker (os) and in minor nerve fibers of the peripheral
innervation of the worm’s body wall. The nerve fibers are varicose in appearance, resembling beads on a string (enlarged region, solid arrows) and are
repeated along the length of the body. The asterisk (*) indicates an area of non-specific fluorescence resulting from tissue damage (B) Z-projection of
an adult male worm labeled with anti-SmACC-2 (green) and phalloidin (red). SmACC-2 immunoreactivity is present in varicose nerve fibers (solid
arrows) that cross the body in a mesh-like pattern indicative of PNS staining. SmACC-2 and the phalloidin –stained body wall musculature are present
at different depths of the animal, suggesting that SmACC-2 does not directly innervate muscle. (C) Tubercles (tb) of an adult male worm labeled with
anti-SmACC-2 and phalloidin. Specific, punctate SmACC-2 immunoreactivity can be seen along the surface and within the tubercles (arrows). (D)
SmACC-2 forms a pattern of concentric, varicose nerve fibers that run the entire length of a 6-day old schistosomulum. A similar expression pattern
was observed in schistosomula labeled with anti-SmACC-1 antibody (not shown). (E) Transmitted light and corresponding fluorescent image of a
negative control worm labeled with peptide-preadsorbed anti-SmACC-1 and (F) the same negative control for peptide-preadsorbed anti-SmACC-2.
The scale bars for the two negative controls are 50 mm (panel E) and 20 mm (panel F).
doi:10.1371/journal.ppat.1004181.g005
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Figure 6. Functional characterization of SmACC-1 in HEK-293 cells. HEK-293 cells were transfected with a human codon-optimized SmACC-1
construct and labeled with affinity-purified anti-SmACC-1 antibody, followed by FITC-conjugated secondary antibody (green). (A) The results show
specific immunoreactivity along the surface of the cells, consistent with protein expression. (B) No immunofluorescence is present in cells transfected
with empty vector (mock control). (C) Schematic representation of the Premo Halide Sensor YFP quench assay. Cells expressing YFP and the chloride
channel of interest are bathed in buffer containing iodide (I2), which is used as a surrogate for chloride ions. Agonist-induced activation of the
channel causes an influx of I2 into the cell and quenches YFP fluorescence. (D) Representative data from individual wells containing cells transfected
with either SmACC-1 or empty vector (mock). Treatment of SmACC-1 expressing cells with 100 mM nicotine (solid red squares) resulted in a significant
reduction in YFP fluorescence (YFP quench) when compared to both a water-treated negative control (solid triangles) and mock-transfected cells
treated with 100 mM nicotine (solid circles). Data were normalized relative to maximum YFP fluorescence for each sample.
doi:10.1371/journal.ppat.1004181.g006
Figure 7. SmACC-1 is selectively activated by cholinergic substances in transfected HEK-293 cells. (A) A panel of cholinergic receptor
agonists (acetylcholine (ACh), choline, carbachol, nicotine, arecoline) was tested against SmACC-1 expressing or mock-transfected cells. The YFP
quench data were normalized relative to the water-treated control measured in the same experiment and on the same plate. Results are the means
and SEM of 3-4 experiments, each containing 6 technical replicates per treatment. All cholinergic agonists caused a significant reduction in YFP
fluorescence at P,0.05 (*) compared to the water control. Treatment of SmACC-1-expressing cells with serotonin (5HT), glutamate or dopamine did
not result in significant YFP quench. (B) SmACC-1 expressing cells were treated with variable concentrations of nicotine and YFP quench was
calculated. The YFP quench data were normalized relative to the maximum response for each experiment and an EC50 value was calculated by
nonlinear regression analysis of the normalized data. The results are the means 6 SEM of 3 independent experiments, each with six replicates.
doi:10.1371/journal.ppat.1004181.g007
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chloride-permeable channels initiate membrane hyperpolariza-
tion, causing an inhibition of action potentials. However, none of
these invertebrate channels has been directly implicated in the
control of motor function.
The effects of ACh on invertebrate neuromuscular activity vary
depending upon the organism in question. As in vertebrates, ACh
has excitatory neuromuscular effects in many invertebrate phyla,
including some helminths such as nematodes and planarians
[53,54]. In trematodes, however, ACh appears to act in exactly the
opposite manner. Exogenous application of cholinergic agonists
onto trematodes in culture causes a rapid flaccid paralysis due to
relaxation of the body wall muscles [15,55]. A similar type of
paralysis was observed in tapeworms (cestodes) treated with
exogenous ACh [16]. This inhibitory response to cholinergic
drugs appears unique to parasitic flatworms (trematodes and
cestodes), and the receptors mediating this activity may therefore
hold value as a therapeutic target. Earlier electrophysiology studies
of S. mansoni tentatively identified these receptors as nAChR-like
based on their pharmacological properties [17] but the receptors
themselves were not identified. The sequencing of the S. mansoni
genome [18–19] led to the annotation of several candidate
nAChR subunit genes, which are the focus of the present work.
Using a combination of BLAST and keyword searches, a total
of nine nAChR subunit genes were found in the genome of S.
mansoni. A structural alignment of the schistosome nAChR
subunits with the Torpedo nAChR was then performed to identify
peptide motifs associated with ion-selectivity. Cation-selective ion
channel subunits have a negatively charged intermediate ring,
formed by the presence of Glu residues in the M1-M2 linking
region [56]. Anion-selective Cys-loop receptor subunits replace
the Glu in this region with a Pro-Ala motif, disrupting the
electrostatic interactions in the intermediate ring and conferring
anion-selectivity to the channel [14, 45, 46 see 47 for review].
The results of our structural alignment indicate that 5 of
the schistosome nAChR subunits (SmACC-1, SmACC-2,
Smp_157790, Smp_037910 and Smp_132070) contain this
anion-selectivity determinant and they were tentatively identified
as S. mansoni SmACCs. Furthermore, a dendrogram analysis
suggests that the SmACCs are evolutionarily distinct from the
ACCs found in C. elegans. Unlike the C. elegans ACCs [12], the
schistosome subunits are structurally related to vertebrate and
invertebrate nAChRs, suggesting that the SmACCs are descended
from ancient nicotinic channels but have evolved selectivity for
chloride. This allies the SmACCs more closely with the anion-
selective nAChRs of the snail Lymnaea [11], with which they share
more than 40% identity at the protein level. Interestingly, certain
species of Lymnaea are permissive intermediate hosts of schisto-
somes. However, it is unclear if the presence of anion-selective
nicotinic channels in both organisms is due to horizontal gene
transfer, common ancestry or convergent evolution. There is also
evidence of closely related, putative nAChR chloride channels
present in the genome of the trematode Clonorchis sinensis [57],
suggesting a unique clade of platyhelminth-specific nicotinic
chloride channels.
The next step after identifying the SmACCs was to study their
role in the motor function of the parasite. The flaccid paralysis of
adult schistosomes caused by treatment with cholinergic com-
pounds is well characterized. However, very little is known about
the role of cholinergic receptors in the motor activity of larval
schistosomula. Given that larval migration is vital to parasite
development and survival [6] and the cholinergic system is a
major regulator of motor function in adult worms, we hypoth-
esized that SmACCs play an important role as inhibitory
modulators in larval neuromuscular function. To test this, two
types of behavioral assay were employed- pharmacological and
RNAi. The results of the pharmacological motility assay agree
with previous studies implicating ACh as an inhibitor of
schistosome movement [15,17]. Treatment of 6-day old schisto-
somula with the cholinergic agonists arecoline and nicotine
caused nearly complete paralysis whereas classical antagonists,
mecamylamine and D-tubocurarine stimulated movement by 3–4
fold over water-treated control animals. These results suggest that
the schistosome cholinergic system mediates inhibitory neuro-
muscular responses, possibly via an influx of chloride generated
by SmACC activation.
Although the results of the pharmacological motility assay agree
with previously published studies, motor phenotypes elicited by
treatment of worms with exogenous compounds are not necessar-
ily of biological or behavioral relevance. Drug permeability across
the tegument, non-selective targeting and toxic effects may all
induce motor behaviors that obscure the role of the receptors in
question. Silencing of receptor function by RNAi mitigates these
issues by targeting receptors individually and by measuring effects
on basal motor activity in the absence of added drugs. The results
of our RNAi assay show that the ion channels formed by the
SmACC subunits act as inhibitory mediators of motor activity in
schistosomula. Knockdown of each of the 5 identified SmACC
subunits resulted in a 3-6-fold hypermotile phenotype, mirroring
the hyperactivity seen in antagonist-treated schistosomula. It is
unclear why the individual subunits all produced similar hyper-
motile RNAi phenotypes. It is possible these are all components of
the same inhibitory channel, such that the loss of any one subunit
results in loss of channel function and hyperactivity. As discussed
below, our immunolocalization studies show that two of these
subunits, at least (SmACC-1 and SmACC-2) have similar
distribution patterns, suggesting they could be components of
the same channel in the worm. Alternatively these could assemble
into different channels that have similar inhibitory effects on
movement.
Figure 8. SmACC-1 is selectively antagonized by D-tubocura-
rine in transfected HEK-293 cells. SmACC-1-expressing cells were
pre-incubated with cholinergic antagonists (mecamylamine, D-tubocu-
rarine, atropine), each at a concentration of 100 mM. Cells were then
treated with 100 mM nicotine and YFP quench was measured. Control
SmACC-1 cells were treated with nicotine in the absence of antagonist.
The YFP quench data were normalized relative to the water-treated
control. Results are the means and SEM of 12 replicates from two
separate transfections.
doi:10.1371/journal.ppat.1004181.g008
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To identify the possible mechanisms by which the SmACCs
mediate inhibitory motor responses, immunolocalization studies
were performed by confocal microscopy. The tissue distribution of
two SmACCs in which silencing elicited large hypermotile
phenotypes, SmACC-1 and SmACC-2, was examined in adult
and larval stages of the parasite. The most significant expression
was observed in the peripheral innervation of the worm’s body
wall, both for SmACC-1 and SmACC-2. Counterstaining with
phalloidin suggests that neither subunit is expressed directly on the
musculature. Rather, SmACC-1 and SmACC-2 were detected in
minor nerve fibers of the submuscular nerve net that innervates
the somatic muscles. This suggests that SmACC-1 and SmACC-2
mediate their inhibitory motor effects in an indirect manner,
perhaps by modulating the release of other neurotransmitters or
by acting as autoreceptors. In flatworms, as well as vertebrate
model systems, nicotinic receptors are well known to mediate the
release of other neurotransmitters, including neuropeptides and
dopamine [58–60]. In schistosomes, the cholinergic and neuro-
peptidergic system (which is excitatory in flatworms), are in very
close proximity [50,61]. The balance between these systems may,
therefore, be an important factor in the regulation of motor
behavior. It would be of interest to determine if ACh inhibits
neuropeptide release through these receptors, and whether this
inhibition might explain the flaccid paralysis and other motor
effects of ACh in these parasites.
SmACC-2 immunoreactivity was also seen on the surface of the
parasite. Discreet, punctate staining is present along and in
between the tubercles of adult male worms and along the surface
of adult females. This marks the second time a nAChR has been
localized to the schistosome tegument [62]. Surface nAChRs in
schistosomes have previously been linked to modulation of glucose
uptake and are postulated to act through tegumental GLUT-1 like
transporters [63]. The possibility also exists that tegumental
SmACC-2 may provide sensory cues affecting motor function.
The tubercles are known to contain innervated sensory structures
[64], which interface with the peripheral nerve net below and
ultimately the CNS. The presence of SmACC-2 at both of these
locations points to a potential role for ACh and this receptor in
mediating host-parasite interactions affecting worm motor behav-
ior.
While behavioral assays and microscopy serve to elucidate the
behavioral role of the SmACCs, they provide only limited insight
into receptor function at the molecular level. Therefore, functional
expression analysis of a SmACC receptor was carried out in a
heterologous expression system. A previous study cloned and
expressed two cation-selective nAChR subunits from S. haemato-
bium in Xenopus oocytes [65]. However, neither subunit was able to
form a functional ion channel either alone or when co-expressed.
Our initial attempts to express SmACC-1 and SmACC-2 failed to
produce functional channels, either individually or in combination
and in two different expression environments, HEK-293 cells and
Xenopus oocytes (data not shown). SmACC-2 lacks the YxCC motif
of nAChR alpha-subunits and therefore is not capable of forming
functional homomeric channels. Further examination with appro-
priate antibodies of cells transfected with the SmACC-1 subunit
determined that the level of protein expression was low, which
could explain the apparent lack of activity. It has been shown that
differences in codon-usage can significantly decrease the expres-
sion of recombinant schistosome proteins in heterologous systems
[66]. Thus we obtained a codon-optimized (humanized) cDNA for
SmACC-1 and repeated the analysis in HEK-293 cells. The
humanized construct produced higher levels of protein expression
and some of this protein appeared to be correctly targeted to the
cell surface, as determined by immunofluorescence analysis.
Subsequent functional studies showed that human codon-opti-
mized SmACC-1 produced a functional homomeric ion channel
in HEK-293 cells. Several nAChR subunits are known to form
functional homomeric channels in vivo. Examples of this include
the vertebrate alpha-7 nAChR and the ACR-16 of C. elegans [67–
68]. However, the expression of functional homomeric nAChRs is
limited to neuronally expressed channels [69]. Moreover, only
alpha-type nAChR subunits are capable of forming homopenta-
meric channels. Thus, the formation of a functional homomeric
SmACC-1 channel, together with its neuronal expression pattern
in the worm, both suggest that SmACC-1 is a neuronal-type alpha
nAChR subunit.
Activity assays were performed using a relatively novel,
fluorescence-based assay, the Premo Halide Sensor (Invitrogen).
The results of the activity assay show that SmACC-1 is activated
by cholinergic agonists but not other biogenic amines. Nicotine
and ACh induced the largest response (< 6-fold and 2.5-fold,
respectively) when compared to water-treated control cells. An
EC50 of 4.3 mM was calculated for nicotine, which falls within the
reported range for vertebrate neuronal nAChR response to
nicotine, as well as an nAChR characterized in the parasitic
nematode A. suum [70–72]. Subsequent pharmacological studies
showed that the response to nicotine was virtually abolished by D-
tubocurarine, suggesting the drug effects on movement are
mediated, at least in part, by this subunit. In contrast, mecamyl-
amine had no effect on the recombinant channel and therefore it
must be acting through nAChRs that do not involve SmACC-1.
Interestingly, the closely related Lymnae ACh-gated chloride
channel was also reported to be insensitive to mecamylamine [11].
Functional analysis of SmACC-1 in a mammalian expression
system represents a departure from the more classical electro-
physiological method in Xenopus oocytes. Although electrophysio-
logical characterization is the gold standard for measurement of
ion channel activity, this method is technically demanding, labor-
intensive and generally unsuitable for screening large numbers of
compounds. In order to mitigate these issues, researchers have
turned to mammalian cell-based ion channel functional assays.
Expression of target ion channels in mammalian cells still allows
direct measurement of ion flux and membrane potential, however
it does so in a high-throughput format. Assays exist for a variety of
ion channel types (Ca2+, Na+, Cl-) and many are commercially
available [reviewed in 73]. Moreover, the data from these HTS
assays generally correlate well with results generated by traditional
electrophysiological methods [73]. The Premo Halide Assay
employed in this study is based upon technology used to identify
small molecule inhibitors of CFTR chloride channels [37]. The
high-throughput format of the assay allows for the possibility of
screening large chemical libraries against parasite receptors that
may have highly divergent pharmacology. Given the major effects
the SmACCs exert over worm motor function, this is an option
worth pursuing.
The work described here adds to the mounting evidence of
acetylcholine’s role as a major inhibitory transmitter in schisto-
somes. We have described a novel clade of nicotinic acetylcholine-
gated chloride channel subunits (SmACCs) that are phylogenetically
distant from the C. elegans ACCs and play a major role in inhibitory
neuromuscular modulation as it pertains to larval motor behavior.
The localization of the SmACCs to the peripheral nervous system
points to their broad, indirect role in this modulation. Functional
studies in mammalian cells indicate that the SmACC subunits are
capable of forming functional nicotinic chloride channels in vitro.
Finally, the use of a fluorescent, mammalian cell-based functional
assay for a helminth ion channel represents a new tool in the search
for new anti-schistosomal drugs.
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Supporting Information
Figure S1 Validation of anti-SmACC antibodies in adult
schistosomes. Crude membrane protein extract from adult S.
mansoni was run on an SDS-PAGE gel, transferred to a PVDF
membrane and probed with affinity-purified anti-SmACC-1
antibody (A) or anti-SmACC-2 antibody (B), followed by
horseradish peroxidase (HRP) conjugated secondary antibody.
The positions of the two immunoreactive bands are indicated.
There was no immunoreactivity in the antigen-preadsorbed
negative control for either antibody.
(TIF)
Table S1 List of Cys-loop receptor sequences used for
phylogenetic analysis of SmACCs.
(XIS)
Table S2 List of PCR primers used for generation of
siRNA and qPCR of SmACCs.
(XIS)
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